|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ishibashi M, Nakayama K, Yeasmin S,
Katagiri A, Iida K, Nakayama N, Fukumoto M and Miyazaki K: A
BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a
potential target for Taxol resistance in ovarian cancer. Clin
Cancer Res. 14:3149–3155. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakayama K, Nakayama N, Davidson B, Sheu
JJ, Jinawath N, Santillan A, Salani R, Bristow RE, Morin PJ, Kurman
RJ, et al: A BTB/POZ protein, NAC-1, is related to tumor recurrence
and is essential for tumor growth and survival. Proc Natl Acad Sci
USA. 103:pp. 18739–18744. 2006; View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jinawath N, Vasoontara C, Yap KL,
Thiaville MM, Nakayama K, Wang TL and Shih IM: NAC-1, a potential
stem cell pluripotency factor, contributes to paclitaxel resistance
in ovarian cancer through inactivating Gadd45 pathway. Oncogene.
28:1941–1948. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nakayama K, Rahman MT, Rahman M, Yeasmin
S, Ishikawa M, Katagiri A, Iida K, Nakayama N and Miyazaki K:
Biological role and prognostic significance of NAC1 in ovarian
cancer. Gynecol Oncol. 119:469–478. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nakayama K, Nakayama N, Wang TL and Shih
IeM: NAC-1 controls cell growth and survival by repressing
transcription of Gadd45GIP1, a candidate tumor suppressor. Cancer
Res. 67:8058–8064. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chung HK, Yi YW, Jung NC, Kim D, Suh JM,
Kim H, Park KC, Song JH, Kim DW, Hwang ES, et al: CR6-interacting
factor 1 interacts with Gadd45 family proteins and modulates the
cell cycle. J Biol Chem. 278:28079–28088. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Cheng Y, Ren X, Hori T,
Huber-Keener KJ, Zhang L, Yap KL, Liu D, Shantz L, Qin ZH, et al:
Dysfunction of nucleus accumbens-1 activates cellular senescence
and inhibits tumor cell proliferation and oncogenesis. Cancer Res.
72:4262–4275. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dimri GP, Lee X, Basile G, Acosta M, Scott
G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O,
et al: A biomarker that identifies senescent human cells in culture
and in aging skin in vivo. Proc Natl Acad Sci USA. 92:pp.
9363–9367. 1995; View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Saretzki G: Cellular senescence in the
development and treatment of cancer. Curr Pharm Des. 16:79–100.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lechel A, Satyanarayana A, Ju Z, Plentz
RR, Schaetzlein S, Rudolph C, Wilkens L, Wiemann SU, Saretzki G,
Malek NP, et al: The cellular level of telomere dysfunction
determines induction of senescence or apoptosis in vivo. EMBO Rep.
6:275–281. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Havelka AM, Berndtsson M, Olofsson MH,
Shoshan MC and Linder S: Mechanisms of action of DNA-damaging
anticancer drugs in treatment of carcinomas: Is acute apoptosis an
‘off-target’ effect? Mini Rev Med Chem. 7:1035–1039. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Odicino F, Pecorelli S, Zigliani L and
Creasman WT: History of the FIGO cancer staging system. Int J
Gynaecol Obstet. 101:205–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shih IeM, Nakayama K, Wu G, Nakayama N,
Zhang J and Wang TL: Amplification of the ch19p13.2 NACC1 locus in
ovarian high-grade serous carcinoma. Mod Pathol. 24:638–645. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang L, Yang Z, Ma A, Qu Y, Xia S, Xu D,
Ge C, Qiu B, Xia Q, Li J and Liu Y: Growth arrest and DNA damage
45G down-regulation contributes to Janus kinase/signal transducer
and activator of transcription 3 activation and cellular senescence
evasion in hepatocellular carcinoma. Hepatology. 59:178–189. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Scott M and Hall PA: Prognostic and
predictive factors. Methods Mol Med. 97:1–11. 2004.PubMed/NCBI
|
|
17
|
Kim J, Chu J, Shen X, Wang J and Orkin SH:
An extended transcriptional network for pluripotency of embryonic
stem cells. Cell. 132:1049–1061. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Rao S, Chu J, Shen X, Levasseur
DN, Theunissen TW and Orkin SH: A protein interaction network for
pluripotency of embryonic stem cells. Nature. 444:364–368. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Levasseur DN and Orkin SH:
Requirement of Nanog dimerization for stem cell self-renewal and
pluripotency. Proc Natl Acad Sci USA. 105:pp. 6326–6331. 2008;
View Article : Google Scholar : PubMed/NCBI
|
